The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy
Open accessAbstract
This large community-based cohort study investigates the impact of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), specifically Liraglutide and Semaglutide, on the risk of developing psychiatric conditions such as depression, anxiety, and suicidal behaviors in patients with obesity. Utilizing post-marketing data, this research compares patients prescribed GLP-1 RAs (cases) with those not taking these medications (controls). The analysis spanned data from January 1, 2015, to December 31, 2023. To minimize selection bias, we employed 1:1 propensity score matching to account for demographic factors such as age, sex, race, and comorbidities. After matching, the study included 162,253 case and control patients. This study showed a significant association between GLP-1 RA treatment and an 98% increased risk of any psychiatric disorders. Notably, patients on GLP-1 RAs exhibited a 195% higher risk of major depression, a 108% increased risk for anxiety, and a 106% elevated risk for suicidal behavior. These findings underscore the critical need for physicians to thoroughly assess patient history before prescribing GLP-1 RAs and highlight the urgent requirement for further prospective clinical trials to fully understand the implications of GLP-1 RA use on mental health in the obese patient population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Suicidal ideation is associated with the use of various weight reduction drugs [67,68].”
From Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning (2025) · cites this paper as [68]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Kornelius et al. reported a three-fold higher risk of major depression, and a doubled risk for anxiety and suicidal behavior in a large (n = 11,683,623) retrospective study of GLP-1RA users utilizing the TrinetX database (100).”
From The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medications (2026) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abarca-Gómez, L., Abdeen, Z. A., Hamid, Z. A., Abu-Rmeileh, N. M., Acosta-Cazares, B., Acuin, C., Adams, R. J., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32129-3 · Cited by 7,482
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2032183 · Cited by 5,205
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., Hardt-Lindberg, S., Hovingh, G. K., Kahn, S. E., Kushner, R. F., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2307563 · Cited by 3,236
Childhood obesity: public-health crisis, common sense cure
Ebbeling, C. B., Pawlak, D. B., & Ludwig, D. S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09678-2 · Cited by 2,980
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C. W., le Roux, C. W., Violante Ortiz, R., Jensen, C. B., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411892 · Cited by 2,724
Body-mass index and mortality among 1.46 million white adults
Berrington de Gonzalez, A., Hartge, P., Cerhan, J. R., Flint, A. J., Hannan, L., MacInnis, R. J., Moore, S. C., Tobias, G. S., Anton-Culver, H., Freeman, L. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000367 · Cited by 2,317
Reeves, G. K., Pirie, K., Beral, V., Green, J., Spencer, E., & Bull, D. (2007) · BMJ · doi:10.1136/bmj.39367.495995.ae · Cited by 1,507
Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., Rosenstock, J., Shimomura, I., Viljoen, A., Wadden, T. A., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00213-0 · Cited by 1,419
Benefits and Risks of Bariatric Surgery in Adults: A Review
Arterburn, D. E., Telem, D. A., Kushner, R. F., & Courcoulas, A. P. (2020) · JAMA · doi:10.1001/jama.2020.12567 · Cited by 1,251
Cited by
Sorted by citations
Moiz, A., Filion, K. B., Tsoukas, M. A., Yu, O. H. Y., Peters, T. M., & Eisenberg, M. J. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103363 · Cited by 157
GLP-1 and Its Analogs: Does Sex Matter?
Börchers, S., & Skibicka, K. P. (2024) · Endocrinology · doi:10.1210/endocr/bqae165 · Cited by 96
Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning
Kim, J. A., & Yoo, H. J. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0242 · Cited by 71
“Suicidal ideation is associated with the use of various weight reduction drugs [67,68].”
Radkhah, H., Anaraki, S. R., Roudsari, P. P., Bahri, R. A., Zooravar, D., Asgarian, S., Dolama, R. H., Alirezaei, A., & Khalooeifard, R. (2025) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-025-01720-9 · Cited by 60
Jalleh, R. J., Talley, N. J., Horowitz, M., & Nauck, M. A. (2026) · Journal of Clinical Investigation · doi:10.1172/jci194740 · Cited by 40
“Along those lines, Kornelius et al. reported a three-fold higher risk of major depression, and a doubled risk for anxiety and suicidal behavior in a large ( n = 11,683,623) retrospective study of GLP-1RA users utilizing the TrinetX database (100).”
Tirzepatide in Adults With Type 1 Diabetes: A Phase 2 Randomized Placebo-Controlled Clinical Trial
SNAITH, J. R., Frampton, R., Samocha‐Bonet, D., & Greenfield, J. R. (2025) · Diabetes Care · doi:10.2337/dc25-2379 · Cited by 44
Wang, M., Chen, X., Liu, Z., Li, Z., Zhu, Z., Liu, S., & Xiao, S. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103385 · Cited by 40
Bailey, C. J., Flatt, P. R., & Conlon, J. M. (2025) · Peptides · doi:10.1016/j.peptides.2025.171380 · Cited by 36
Kong, F., Zhao, Y., Zhang, W., Wang, X., Wu, T., Zhou, Z., Xu, Y., Xia, L., & Sun, T. (2026) · Nature Communications · doi:10.1038/s41467-025-67701-9 · Cited by 29
McIntyre, R. S., Rasgon, N., Goldberg, J. F., Wong, S., Le, G. H., Mansur, R. B., Rosenblat, J. D., Teopiz, K. M., & Stahl, S. M. (2025) · CNS Spectrums · doi:10.1017/s1092852925000124 · Cited by 32
Glucagon-like peptide-1 receptor agonists in arthritis: current insights and future directions
Karacabeyli, D., & Lacaille, D. V. (2025) · Nature Reviews Rheumatology · doi:10.1038/s41584-025-01302-0 · Cited by 31
Gastrointestinal Motility Effects of GLP-1 Receptor Agonists
Bellavance, D. R., Chua, S. G., & Mashimo, H. L. (2025) · Current Gastroenterology Reports · doi:10.1007/s11894-025-00995-3 · Cited by 27
Mechanisms of GLP-1 in Modulating Craving and Addiction: Neurobiological and Translational Insights
Alves, G. A. M., Teranishi, M., Ortega, A. C. T. D. C. G., James, F., & Arachchige, A. S. P. M. (2025) · Medical Sciences · doi:10.3390/medsci13030136 · Cited by 32
Valentino, K., Teopiz, K. M., Cheung, W., Wong, S., Le, G. H., Rosenblat, J. D., Mansur, R. B., & McIntyre, R. S. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.02.008 · Cited by 23
Nishida, K., Chrétien, B., Dolladille, C., Ebina, T., Aleksić, B., Cabé, N., Savey, V., Onoue, T., & Yatsuya, H. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.06.011 · Cited by 28
The future of psychiatry: clinical practice, diagnosis, and treatment
Turner, S., Yadav, P., Morrin, H., & Bhat, A. (2025) · International Review of Psychiatry · doi:10.1080/09540261.2025.2594523 · Cited by 23
Taipale, H. T., Taylor, M., Lähteenvuo, M., Mittendorfer-Rutz, E., Tanskanen, A. J., & Tiihonen, J. (2026) · The Lancet Psychiatry · doi:10.1016/s2215-0366(26)00014-3 · Cited by 23
Badulescu, S., Gill, H., Shah, H., Brudner, R. M., Phan, L., Vincenzo, J. D. D., Tabassum, A., Armanyous, M., Llach, C.-D., Rosenblat, J. D., et al. (2025) · Med · doi:10.1016/j.medj.2025.100916 · Cited by 20
Li, S., Sabbah, S. G., Kwan, A. T. H., & McIntyre, R. S. (2025) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2025.08.002 · Cited by 19
Wang, M., Yang, Z., Yan, M., Shao, L., & Xiao, S. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119670 · Cited by 18
Chang, Y., Hsieh, M., Ju, P., & Chang, C. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70175 · Cited by 20
Incretin-Based Therapies Through the Decades: Molecular Innovations and Clinical Impact
Lee, A. A., Khotina, V. A., Kashirskikh, D. A., Voronko, O. E., Gasanov, V. A. O., & Vasiliev, A. V. (2025) · Medical Sciences · doi:10.3390/medsci13040269 · Cited by 21
Krug, I., Dang, A. B., Portingale, J., Li, Y., & Won, Y. Q. (2025) · Nutrients · doi:10.3390/nu17233735 · Cited by 19
Clinical management of major depressive disorder with comorbid obesity
Opel, N., Hanßen, R., Steinmann, L. A., Roempler, J., Köhler‐Forsberg, O., Hahn, M., Ferretti, F., Palmer, C., Penninx, B. W. J. H., Gold, S. M., et al. (2025) · The Lancet Psychiatry · doi:10.1016/s2215-0366(25)00193-2 · Cited by 20
Siddiqui, H. F., Ali, D., Sajid, M., Qureshi, S., Siddiqui, H., Hasan, A., Ripley, D. P., Ahmed, R., & Waqas, S. A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70123 · Cited by 20
Metabolic Modulators in Depression: Emerging Molecular Mechanisms and Therapeutic Opportunities
Dyndał, K., Pańczyszyn-Trzewik, P., & Sowa-Kućma, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178755 · Cited by 17
Integration of Glucagon-Like Peptide 1 Receptor Actions Through the Central Amygdala
Duran, M., Willis, J. R., Dalvi, N., Fokakis, Z. N., VIRKUS, S., & Hardaway, J. A. (2025) · Endocrinology · doi:10.1210/endocr/bqaf019 · Cited by 12
Dymek, A., Zielińska, M., Englert-Bator, A., Dereń, K., & Łuszczki, E. (2025) · Nutrients · doi:10.3390/nu17172835 · Cited by 17
Llach, C.-D., Badulescu, S., Tabassum, A., Shah, H., Gill, H., Le, G. H., Vieta, E., McIntyre, R. S., Rosenblat, J. D., & Mansur, R. B. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03261-0 · Cited by 15
GLP-1 and Its Role in Glycogen Production: A Narrative Review
Lotosky, J., Jean, X., Altankhuyag, A., Khan, S. R., Bernotas, A., Sharafshah, A., Blum, K., Posner, A. R., & Thanos, P. K. (2025) · Biomedicines · doi:10.3390/biomedicines13071610 · Cited by 14
Glucagon-Like Peptide-1 Receptor Agonists in Psychiatry: A Pharmacoepidemiological Scoping Review
Volkow, N. D., & Xu, R. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.03.1002 · Cited by 11
Katranski, J., Liang, S., Morris, D., Suppiah, V., & Lim, C. X. (2025) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-025-01943-x · Cited by 10
Ruggiero, R., Longo, M., Mascolo, A., Nuzzo, M. D., Laino, L. V., Caruso, P., D'Amato, R., Rafaniello, C., Maiorino, M. I., Esposito, K., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178004 · Cited by 9
Przybyłowski, A., Górski, M. K., Gwioździk, W., & Polaniak, R. (2025) · Healthcare · doi:10.3390/healthcare13161967 · Cited by 11
Glucagon-like peptide-1 medicines in neurological and psychiatric disorders
Fang, S., Cui, F., & Drucker, D. J. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102511 · Cited by 9
GLP‐1 at the Metabolic–Cognitive Interface: Reward, Affect, and Memory
Gao, S., Décarie-Spain, L., Gu, C., Mazzini, G., Kanoski, S. E., & Borner, T. (2026) · Comprehensive physiology · doi:10.1002/cph4.70129 · Cited by 11
McIntyre, R. S. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20241087 · Cited by 10
Carminati, M., Tondello, M., Concina, A., Olgiati, P., & Zanardi, R. (2025) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000595 · Cited by 8
Her, Q. L., Wang, T., Stürmer, T., Buse, J. B., Funk, M. J., Pate, V., & Webster‐Clark, M. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70002 · Cited by 8
A Brain Reward Circuit Inhibited By Next-Generation Weight Loss DrugsPreprint
Godschall, E., Güngül, T. B., Sajonia, I. R., Buyukaksakal, A. K., Li, O. D.-A., Ogilvie, S., Keeler, A. B., Tian, G., Koita, O., Shi, Y., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.12.628169 · Cited by 8
He, X., Zhao, Z., Sun, Y., & Jiang, X. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118163 · Cited by 8
Schaefer, L. M., Williams‐Kerver, G. A., Allison, K. C., Kohoutek, B., & Steffen, K. J. (2025) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2025.08.013 · Cited by 8
Osborne, D., & Abdelgadir, E. (2026) · International Journal of Obesity · doi:10.1038/s41366-025-02002-1 · Cited by 7
Aboukaoud, M., Hoch, B., Weiser, M., & Amiaz, R. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121802 · Cited by 6
Stojkovska, A., Prelog, P. R., & Palandačić, A. K. (2025) · Journal of International Medical Research · doi:10.1177/03000605251349393 · Cited by 7
Glucagon-Like Peptide-1 Receptor Agonists for Mood Disorders and Suicide Risk
McIntyre, R. S. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.04.019 · Cited by 6
Li, W., Cai, R., Yin, B., Zhou, Y., Dong, X., Li, W., & Wen, J. (2025) · Biology · doi:10.3390/biology14050575 · Cited by 4
Biased histamine signaling selectively gates fat preference
Zheng, Y., Liao, J., Fang, Z., Tang, X., Zhou, Z., Zhao, X., Li, M., Liu, M., Xu, S., Chen, J., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.10.035 · Cited by 4
Research Priorities and Future Directions in Cardio-Oncology
Mszar, R., Ali, A., Hull, S. C., Ferrucci, L. M., Baldassarre, L. A., Khera, R., Irwin, M. L., & Clasen, S. C. (2026) · Current Treatment Options in Oncology · doi:10.1007/s11864-025-01366-w · Cited by 5
Beyond weight loss: multisystem benefits of obesity medications
Savas, M., Kuckuck, S., Boon, M. R., & van Rossum, E. F. C. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(26)00100-2 · Cited by 4
Blunted anticipation but not consummation of food rewards in depression
Schulz, C., Klaus, J., Peglow, F., Ellinger, S., Kühnel, A., Walter, M., & Kroemer, N. B. (2024) · Cell Reports Medicine · doi:10.1016/j.nsa.2024.103981 · Cited by 4
Martinelli, S., & Petrucciani, N. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06989-3 · Cited by 3
The effect of GLP-1 receptor agonists on anxiety: A systematic review
Yi, Y. T., Zheng, Y. J., Bargiota, S. I., Dri, C. E., Teopiz, K. M., Wong, S., Le, G. H., Kwan, A. T. H., Cao, B., Ho, R., et al. (2026) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2026.107844 · Cited by 3
Stanislaus, C., Winther‐Jensen, M., Stanislaus, S., Osler, M., Coello, K., & Vinberg, M. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03619-y · Cited by 3
Microbiota-driven gut-brain signaling underlies antidepressant effects of a GLP-1 analog
Bian, L., Cai, Y., Zhang, Y., Shen, L., Wang, H., Gao, F., Cai, N., Chen, W., You, C., Yang, Y., et al. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.05.003 · Cited by 3
Self-citationEdinger-Westphal Urocortin-1 neurons regulate consumption and affect
Bluett, R. J., Yu, Y., Pauli, J. L., Campos, C., & Palmiter, R. D. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115814 · Cited by 3
Glucagon-like Peptide-1 Receptor Agonists: A New Frontier in Treating Alcohol Use Disorder
Oesterle, T., & Ho, M. (2025) · Brain Sciences · doi:10.3390/brainsci15070702 · Cited by 4
Griffiths, A., Shannon, O. M., Spreckley, M., Austin, K., Fallows, E., Clare, K., Ells, L. J., & Matu, J. (2025) · medRxiv · doi:10.64898/2025.12.11.25342052 · Cited by 3
What is the Role of Primary Prevention of Obesity in an Age of Effective Pharmaceuticals?
Gómez‐Martín, M., Canfell, O. J., Chai, L. K., Jansson, A. K., Littlewood, R., Sullivan, C. M., Power, D. D., Clarke, E. D., Ells, L. J., de Vlieger, N., et al. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00632-0 · Cited by 3
Adverse effects and other aspects of drugs with incretin effect
Ballesteros-Pomar, M. D., & Lesmes, I. B. (2025) · Medicina Clínica (English Edition) · doi:10.1016/j.medcli.2025.107041 · Cited by 3
Kim, J.-W. (2025) · Journal of Yeungnam Medical Science · doi:10.12701/jyms.2025.42.61 · Cited by 2
Hofstad, M., & Abreu, I. D. (2026) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000920 · Cited by 2
Pan, J. Y., Elman, I., Panchal, K., Ramsey, K. M., Albanese, M. A., Elman, D. J., & Ramsey, D. J. (2026) · Journal of General Internal Medicine · doi:10.1007/s11606-026-10515-2 · Cited by 2
Zhang, T., He, P., Ji, Y., Shi, J., Zhang, Z., Wang, K., Pan, H., Yao, H., Xue, Y., Zheng, R., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01567-z · Cited by 2
Evaluating Anti‐Diabetic Effect of Courmarin Derivative Aesculetin in Rats with Diet‐Induced Obesity
Wu, B., Wang, J., Sun, G., Li, K., Chen, Q., Wang, Y., He, X., Li, S., & Yang, W. (2025) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2712 · Cited by 2
Assessing the antidepressant effects of GLP-1 receptor agonists using Mendelian randomization
Guo, Q., Yong, W., Guo, L., & Shang, S. (2025) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2025.104416 · Cited by 1
Olowo‐Oribi, B. A., & Salway, R. J. (2025) · Academic Emergency Medicine · doi:10.1111/acem.70088 · Cited by 1
Semaglutide Overdose in a Diabetic Patient: Suicidal Behavior and Multiorgan Failure
Zamir, D., Ovadia, Y. S., Ben‐Bassat, O., Zamir, M., & Malnick, S. D. H. (2025) · American Journal of Case Reports · doi:10.12659/ajcr.947682 · Cited by 1
Mykhaylenko, O. Y., & Єлізарова, О. Т. (2025) · Galician Medical Journal · doi:10.21802/e-gmj2025-a27 · Cited by 1
Mood Disorders, Metabolic Bariatric Surgery, and Weight Loss Pharmacotherapy: a Research Update
Barbuti, M., Weiss, F., & Perugi, G. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00674-4 · Cited by 1
VOLTA DOS TRANSTORNOS ALIMENTARES COM O USO DE AGONISTAS DO RECEPTOR DE GLP-1: UMA REVISÃO NARRATIVA
Cavalcante, M. B. Á., & Cavalcante, G. Á. (2025) · Aracê. · doi:10.56238/arev7n12-037 · Cited by 1
Liu, T., Hsu, C.-H., Wu, J., Huang, P., Chang, C., & Lai, C.-C. (2025) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2025.11.016 · Cited by 3
Marano, G., Rossi, S., Lisci, F. M., Traversi, G., Mazza, O., Claro, A. E., Pola, R., Pitocco, D., Sani, G., Gaetani, E., et al. (2025) · Aging advances. · doi:10.4103/agingadv.agingadv-d-25-00027 · Cited by 1
The Ethics of Wegovy in Pediatric Mental Health
Ryan, N., & Savulescu, J. (2026) · Bioethics · doi:10.1111/bioe.70087 · Cited by 1
Warden, B. A., Duell, P. B., Bucheit, J. D., & Purnell, J. Q. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.11.013 · Cited by 1
Ouyang, C., Zhang, X., Zhang, M., Yan, M., Zhu, Z., Zeng, Y., Ban, H., Wu, Y., Peng, N., Ling, J., et al. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121452 · Cited by 1
Choi, W.-S., Song, M.-K., Seo, M. W., Woo, Y. S., & Bahk, W. (2026) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253261419609 · Cited by 1
Resistant and Refractory Obesity: The Complexity of Anti-Obesity Therapy Failure
Nicze, M., Borówka, M., Dec, A., Bułdak, Ł., Bołdys, A., & Okopień, B. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062539 · Cited by 4
Exendin-4 enhances GLP-1 signaling and reduces anxiety-like behaviors in male heroin withdrawal mice
Xiang, Y., Yan, X., Li, R., Li, C., Yin, D., Luo, C., Xiong, Y., Hong, Y., Li, Y., & Xia, B. (2026) · PLoS ONE · doi:10.1371/journal.pone.0343995 · Cited by 1
Byun, S., Sotzen, M. R., Knappenberger, M. A., Olekanma, D. I., Bento, M. T., & Skibicka, K. P. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04011-8 · Cited by 2
Borovčanin, M., & Petrović, I. (2026) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2026.1869086 · Cited by 1
Targeting the GLP-1 receptor pathways for dual management of obesity and depression
Keswani, R., & Bhatt, S. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104727 · Cited by 1
Kim, C., Kim, S., Lee, D. Y., Han, E., Lee, Y., & You, S. C. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70985 · Cited by 1
New directions in childhood obesity treatment – A path forward or wishful thinking?
Reilly, J. L., Arora, S., Chatman, K., Cooper, Z., & Hsia, D. S. (2025) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.05.010 · Cited by 1
Liraglutide for Children 6 to <12 Years of Age with Obesity
Fox, C. K., Harder-Lauridsen, N. M., & Arslanian, S. A. (2025) · New England Journal of Medicine · doi:10.1056/nejmc2503084 · Cited by 1
Kim, Y. Y., Kim, J. H., & Shin, J. (2024) · Precision and Future Medicine · doi:10.23838/pfm.2024.00170 · Cited by 1
Levinson, J. A., Clifford, D. E., Laing, E. M., Harris, C., Slagel, N., Squires, N. D., & Hunger, J. M. (2025) · Journal of Nutrition Education and Behavior · doi:10.1016/j.jneb.2025.05.194
The Role of GLP-1RAs in Depression among Patients with Metabolic Conditions
Cemelus, M. F. (2025) · Lynchburg Journal of Medical Science · doi:10.63932/3067-7106.1037
Effects of semaglutide on mental health
Rozhdestvenskaya, V. A., Iuzbashian, P. G., Romanov, D. V., Shchurenkov, A. V., Kazaryan, P. A., Sheyanov, A. M., Zubacheva, E. O., & Fedyainova, I. K. (2025) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202512509128
Central nervous system stimulants and drugs that suppress appetite
Sweeney, A. M., & Bello, N. T. (2025) · Side effects of drugs annual · doi:10.1016/bs.seda.2025.10.006
Cheng, Z., Liu, M., Li, X., Tang, J., & Huang, C. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1700100
Self-citationCapitalizing on the GLP-1 RA revolution for behavioral health through digital companions
Naegele, C., & Jones, G. B. (2025) · Digital Health · doi:10.1177/20552076251406308
Tang, H., Lu, Y., Zhang, B., Zhang, D., Zhou, T., Chen, J., Lu, Y., Lyu, T., Zheng, K., & Chen, Y. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.113038
Depression bei somatischen Erkrankungen
Chae, W. R., & Otte, C. (2025) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-025-4414-4
Chang, C.-I., Lin, J.-F., Chen, I., Lin, C.-H., Chen, H.-H., Chang, M., Tang, C., & Pai, Y. (2025) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2025.103373
Cai, J., Dai, S., Shao, P., & Wu, R. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-04982-x
Analysis of Spontaneous Reports of Psychiatric Adverse Events Associated with GLP-1 Analogues
Kowalski, P., & Nowak, M. (2022) · Annals of Pharmacy Practice and Pharmacotherapy · doi:10.51847/bl9xxfe3dd
Kalamaras, H., White, R. T., Coon, S. A., Perkel, M., & Elmaoued, A. A. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261416077
Metadata
- Authors
- Kornelius, E., Huang, J.-Y., Lo, S.-C., Huang, C.-N., & Yang, Y.-S.
- Affiliations
- Chung Shan Medical University Hospital (TW)
- Corresponding author
- Yang, Yi-Sun
- Venue
- Scientific Reports
- Published
- 2024-10-18
- Volume
- 14
- Issue
- 1
- Pages
- 24433-24433
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC11489776
- OpenAlex
- W4403514301
- Cited by
- 143
- References
- 46
- Citations by year
- 2026: 70 · 2025: 68 · 2024: 4
- FWCI
- 46.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Chung Shan Medical University Hospital (CSH-2020-C-016)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- GLP-1 receptor agonists, obesity, depression, anxiety, suicidal behavior, psychiatric adverse effects, liraglutide, semaglutide, mental health, drug safety
- MeSH terms
- Liraglutide, Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, Adult, Aged, Anxiety, Depression, Glucagon-Like Peptides, Female, Humans, Hypoglycemic Agents, Male, Middle Aged, Obesity, Risk Factors, Cohort Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
